Bayer Aleve Line Expanding With Cold & Sinus Offering
This article was originally published in The Tan Sheet
Executive Summary
Bayer Consumer Care will be extending its Aleve line of pain relievers into the cough/cold category following FDA's approval of Aleve Cold & Sinus Nov. 29.
You may also be interested in...
Aleve Cold & Sinus Bolstered By $19 Mil. Ad Spend
Bayer Consumer Care's Aleve Cold & Sinus - "the only brand that can provide all day relief of pain and nasal congestion with just one pill" - will arrive on food, drug and mass shelves nationwide in August. The launch comes nearly nine months after FDA approval.
Aleve Cold & Sinus Bolstered By $19 Mil. Ad Spend
Bayer Consumer Care's Aleve Cold & Sinus - "the only brand that can provide all day relief of pain and nasal congestion with just one pill" - will arrive on food, drug and mass shelves nationwide in August. The launch comes nearly nine months after FDA approval.
Aleve Cold & Sinus Bolstered By $19 Mil. Ad Spend
Bayer Consumer Care's Aleve Cold & Sinus - "the only brand that can provide all day relief of pain and nasal congestion with just one pill" - will arrive on food, drug and mass shelves nationwide in August. The launch comes nearly nine months after FDA approval.